Literature DB >> 6215194

Mouse rosette positive B cells stimulate poorly in the autologous and allogeneic mixed lymphocyte reaction.

F R Davey, A S Kurec.   

Abstract

Mouse erythrocytes form spontaneous rosettes with a population of B lymphocytes from normal individuals and in the majority of lymphocytes from patients with B cell chronic lymphocytic leukaemia (CLL). We have compared the ability of mouse rosette positive (MR+) cells with mouse rosette negative (MR-) cells and monocytes to act as stimulators in the autologous mixed lymphocyte reaction (AMLR) and allogeneic mixed lymphocyte reaction (MLR). Mononuclear cells from the peripheral blood of healthy individuals were fractionated into T cells, MR+ cells, MR- cells and monocytes. Lymphocyte cultures were harvested on days 6, 8 and 10 and the incorporation of tritiated thymidine was determined. MR- cells and monocytes were potent stimulators in the AMLR and MLR. In contrast MR+ cells, like B cells from patients with CLL, stimulated less in the AMLR and MLR. We conclude that MR+ cells from normal individuals function similarly to cells from CLL in the AMLR and MLR.

Entities:  

Mesh:

Year:  1982        PMID: 6215194      PMCID: PMC1536641     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Formation of mouse red cell rosettes by "hairy" cells.

Authors:  D Catovsky; M Papamichail; A Okos; E Miliani; E J Holborow
Journal:  Biomedicine       Date:  1975-04-10

2.  Formation of mouse or sheep red-blood-cell rosettes by lymphocytes from normal and leukaemic individuals.

Authors:  G Stathopoulos; E V Elliott
Journal:  Lancet       Date:  1974-04-06       Impact factor: 79.321

3.  Immunoglobulins on the surface of human lymphocytes.

Authors:  M Papamichail; J C Brown; E J Holborow
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

4.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

5.  Mouse red-cell rosettes in B-lymphoproliferative disorders.

Authors:  D Catovsky; M Cherchi; A Okos; U Hegde; D A Galton
Journal:  Br J Haematol       Date:  1976-06       Impact factor: 6.998

6.  Rosette formation with mouse erythrocytes: probable marker for human B lymphocytes.

Authors:  S Gupta; M H Grieco
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

7.  The human rosette-forming cell as a marker of a population of thymus-derived cells.

Authors:  J Wybran; M C Carr; H H Fudenberg
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

8.  Ontogeny of lymphocyte subpopulations in human fetal liver.

Authors:  S Gupta; R Pahwa; R O'Reilly; R A Good; F P Siegal
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

9.  Interaction of aggregated -globulin with B lymphocytes.

Authors:  H B Dickler; H G Kunkel
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

10.  Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes.

Authors:  M M Kuntz; J B Innes; M E Weksler
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  3 in total

1.  Two distinct stages of B-cell defects in X-linked agammaglobulinaemia.

Authors:  A Dobozy; S Husz; J Hunyadi
Journal:  J R Soc Med       Date:  1986-01       Impact factor: 5.344

2.  Mouse rosette positive B cells fail to synthesize immunoglobulin following incubation with pokeweed mitogen.

Authors:  F R Davey; A S Kurec; H V Lamberson
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

3.  In vitro immunoglobulin synthesis by lymphocytes from patients with rheumatoid arthritis. I. Effect of monocyte depletion and demonstration of an increased proportion of lymphocytes forming rosettes with mouse erythrocytes.

Authors:  C Plater-Zyberk; M F Clarke; K Lam; P A Mumford; G R Room; R N Maini
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.